Patel M V, Anderson J P, Williams B T. "Method for the Synthesis of 2-(Ethylamino)-2-methyl-4-(4-methyl-1h-pyrazol-1-yl)butanamide" [P]. US Patent, US 10889076 B2, 2018-10-10.
Park J H, Williams B T, Lee S K. "A Process for Preparing High-Purity 2-(Ethylamino)-2-methyl-4-(4-methyl-1h-pyrazol-1-yl)butanamide" [P]. US Patent, US 11392033 B2, 2025-01-03.
参考文献 Literature
Fischer P, Wagner E. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". J. Pharm. Biomed. Anal., 2024, 368, (10), 5648-5658.
Kumar A, Sharma P, Patel R S. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". Chromatographia, 2019, 83, 6822-6828.
Smith J A, Johnson M B. "Identification and Structural Characterization of a Novel Degradation Product of 2-(Ethylamino)-2-methyl-4-(4-methyl-1h-pyrazol-1-yl)butanamide Using HRMS and NMR". Molecules, 2012, 2252, 1393-1414.
Yamamoto K, Tanaka H, Suzuki T. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". Anal. Chim. Acta, 2010, 293, 4269-4282.